Andrea Burnett-Hartman, PhD, MPH

Investigator

Andrea Burnett-HartmanAndrea Burnett-Hartman, PhD, MPH, is an Investigator at the Institute for Health Research. Her research focuses on understanding factors associated with colorectal cancer, precursor lesions, and colorectal cancer screening. Dr. Burnett-Hartman is also working to develop and test protocols for using medical informatics to extract data from electronic medical records.

Dr. Burnett-Hartman received her Master of Public Health degree from the University of Michigan and completed her doctoral training in epidemiology at the University of Washington. While in Seattle, she completed her post-doctoral training at the Fred Hutchinson Cancer Research Center. Her current research is aimed at understanding the clinical importance of subsets of serrated polyps, with the ultimate goal of defining the risk of colorectal cancer in those with different types of serrated polyps and improving the effectiveness of colorectal cancer screening and surveillance. She is a co-investigator for the Cancer Research Network (CRN), the Kaiser Permanente Research Bank, and the for the National Institutes of Health(NIH)-sponsored multi-site initiative, Population-based Research Optimizing Screening through Personalized Regimens (PROSPR).

Dr. Burnett-Hartman is an Affiliate Instructor in the Department of Epidemiology at the University of Washington School of Public Health as well as an Affiliate Investigator at the Fred Hutchinson Cancer Research Center.


Selected Research

  • A Cohort Study of Sessile Serrated Polyps and Subsequent Colorectal Neoplasia

    Recent evidence implicates an additional group of polyps, sessile serrated polyps, as potential precursors to a subset of colorectal cancer. This project will investigate the clinical significance of sessile serrated polyps, with the long-term goal of identifying new groups that are high-risk for colorectal cancer and improving the effectiveness of colorectal cancer screening.
    Funder: National Cancer Institute
    Study End Date: 3/31/2018

  • PROSPR Statistical Coordinating Center (PSCC)
    The goal of the PROSPR Statistical Coordinating Center (PPSCC) is to coordinate the research of PROSPR Research Centers (PRCs) to achieve PROSPR's mission of evaluating and improving the cancer screening process (recruitment, screening, diagnosis, and referral for treatment).
    Funder: National Cancer Institute
    Study End Date: 9/19/2017

  • The Association Between Molecular Markers in Colorectal Sessile Serrated Polyps and Colorectal Cancer Risk
    This project proposes to identify biomarkers in sessile serrated polyps that are associated with an increased risk of colorectal cancer. These biomarkers may later be used to guide colorectal cancer surveillance recommendations or included in stool-based DNA panels to improve the effectiveness of stool-based colorectal cancer screening tests.
    Funder: Department of Defense
    Study End Date: 7/31/2018

  • KP Precision Medicine Assessment and Response
    Funder: Garfield Memorial Fund
    Study End Date: 8/15/2018

  • Kaiser Permanente National Research Bank
    The KP National Research Bank is a collaboration across all Kaiser regions nationally funded by Kaiser Foundation Health Plan. The goal of the KP National Research Bank is to collect blood samples from 500,000 adult KP members and utilize them, combined with survey data and medical information to create a state of the art resource for genetic and health services research.
    Funder: Kaiser Foundation Health Plan
    Study End Date: 12/31/2018